Skip to main content
. 2024 Jul 26;14:17233. doi: 10.1038/s41598-024-68107-1

Figure 5.

Figure 5

The Cas9 hybrids do not edit DNA in human cells. (A) Schematic representation of the GFP gene construction used for the editing assay using Cas9 nucleases. Each position targeted by the sgRNA used are shown with different triangles. This representation is not to scale. CMV-TetON is a doxycycline-inducible promoter. (B) Timeline of experiment used for the GFP assay. (C) Percentage of GFP negative cells for the 4 targets used at day 6 (green), 8 (orange) and 10 (yellow) for Sp, SaSp Merry and SaSp Gollum. (D) T7 endo I assay results for targets 1 and 3. The white arrows indicate the cleavage products indicative of efficient editing. Uncropped gels are found in Supplementary Fig. 7. (E) Percentage of GFP positive cells for each condition. Dashed lines represent the gate containing the brightest 1% of the cells transfected with Cas9 only.